CF
56
3
EXR
62
7
AIV
51
3
PAYX
65
5
RIG
35
-3
HSY
27
-4
BA
53
-3
ADM
44
8
KEY
57
-10
DRI
63
2
ILMN
52
3
RL
85
2
PYPL
77
2
CNX
67
2
GS
68
-11
MO
56
5
HSIC
59
2
LRCX
64
-7
FIS
68
3
CI
40
4
CF
56
3
EXR
62
7
AIV
51
3
PAYX
65
5
RIG
35
-3
HSY
27
-4
BA
53
-3
ADM
44
8
KEY
57
-10
DRI
63
2
ILMN
52
3
RL
85
2
PYPL
77
2
CNX
67
2
GS
68
-11
MO
56
5
HSIC
59
2
LRCX
64
-7
FIS
68
3
CI
40
4
Financhill
Back

Avidity Biosciences Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
47

RNA
Avidity Biosciences

Last Price:
$30.37
Seasonality Move:
28.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Avidity Biosciences Stock Forecast

  • Over the next 52 weeks, Avidity Biosciences has on average historically risen by 23.2% based on the past 4 years of stock performance.
  • Avidity Biosciences has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Avidity Biosciences Stock Undervalued?
    The current Avidity Biosciences [RNA] share price is $30.35. The Score for RNA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Avidity Biosciences Stock Go Up Next Year?

  • Over the next 52 weeks, Avidity Biosciences has on average historically risen by 23.2% based on the past 4 years of stock performance.

Avidity Biosciences Stock Rating

Sell
47
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences overpriced?

  • Avidity Biosciences has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Avidity Biosciences Stock Price History

Is RNA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aviditybiosciences.com

52-Week Data

52-Week High:
56.00
52-Week Low:
21.51

Prediction Charts

Market Cap:
3.7B
Price in USD:
30.35
Volume:
1.3M
Beta:
1.01

Technical Analysis

SMA50:
29.51
SMA100:
30.25
SMA200:
36.88
52-Wk Change:
5.68%

Stock Predictions

  • Is Avidity Biosciences stock public?
    Yes, Avidity Biosciences is a publicly traded company.
  • What is the Avidity Biosciences stock quote today?
    The Avidity Biosciences stock price is 30.35 USD today.
  • How to buy Avidity Biosciences stock online?
    You can buy Avidity Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 30.91 32.16 32.19 30.67
Apr-30 31.48 32.65 32.97 31.24
May-1 32.65 32.69 33.10 31.01
May-2 32.69 32.20 33.62 32.02
May-5 31.92 32.28 32.70 31.45
May-6 31.85 26.26 32.03 25.71
May-7 27.11 26.17 27.41 25.58
May-8 26.18 28.69 29.85 25.67
May-9 29.00 27.87 30.25 27.80
May-12 28.48 29.33 31.20 28.48
May-13 29.72 29.88 29.98 28.18
May-14 30.19 28.40 30.84 27.71
May-15 28.35 28.97 29.09 27.65
May-16 29.00 30.35 30.45 28.78

Avidity Biosciences Earnings

Avidity Biosciences Earnings Report: Per Share Avidity Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.

Avidity Biosciences Forecast Revenue Growth

Avidity Biosciences Stock Analysis: Historical quarterly revenues per share for Avidity Biosciences and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.12 per share, a decrease this year of $1.10 per share, and a decrease next year of $0.47 per share.

* Avidity Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.